Bronstein Ben 4
4 · Aldeyra Therapeutics, Inc. · Filed Jun 6, 2024
Insider Transaction Report
Form 4
Bronstein Ben
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-04+2,778→ 2,778 totalExercise: $4.09Exp: 2034-06-03→ Common Stock (2,778 underlying) - Award
Stock Option (Right to Buy)
2024-06-04+40,282→ 40,282 totalExercise: $4.09Exp: 2034-06-03→ Common Stock (40,282 underlying) - Award
Stock Option (Right to Buy)
2024-06-04+2,604→ 2,604 totalExercise: $4.09Exp: 2034-06-03→ Common Stock (2,604 underlying)
Footnotes (3)
- [F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
- [F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.
- [F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.